Rebrook Jason C

Director Rebrook buys 5,000 AROC shares at $23.94; 3rd consecutive buy in 4 days as stock trades -15.7% from 52-week high

Jason C Rebrook, a director at Archrock, Inc., purchased 5,000 shares at $23.94 on 2025-09-22, increasing his holdings to 79.5K shares. This is his third consecutive buy at AROC over a 4-day window (2025-09-18, 2025-09-19, 2025-09-22), representing cumulative discretionary buying activity. The stock is currently 15.7% below its 52-week high of $30.34, and the company's fundamentals remain solid with quarterly revenue of $383.2M, net income of $63.4M, and annual revenue growth of 16.9%. The clustering of three buys within 4 days at depressed valuations relative to the 52-week range, coupled with the company's positive earnings and growth trajectory, suggests deliberate accumulation during a pullback period. Investors should monitor whether this pattern continues and track the stock's recovery relative to the 52-week high.

Director Rebrook Jason C purchases 10,000 shares of AROC at $24.16; position increases to 74,511 shares.

Jason C. Rebrook, a Director, purchased 10,000 shares at $24.16 on 2025-09-19, expanding his holdings by +15.5% to 74,511 shares post-transaction. The stock currently trades at $24.48, representing a -19.3% decline from its 52-week high of $30.34. His cross-ticker track record shows only 2 prior open-market buys with no measurable 90-day outcomes, providing limited historical context for assessing timing precision. The company exhibits solid fundamentals with $383.2M in latest-quarter revenue and +16.9% annual revenue growth, yet the P/E of 18.55 and recent -2.9% 30-day price decline warrant monitoring against the stock's broader downtrend from its 52-week peak.

Director Rebrook buys 10,000 shares at $24.17; holdings rise 18.3% to 64,511 shares in strong AROC fundamentals

Rebrook Jason C, a Director, purchased 10,000 shares at $24.17 on 2025-09-18, expanding his position by 18.3% from 54,511 to 64,511 shares and deploying $241,670.00 in capital. The purchase occurs at a price 20.6% below the 52-week high of $30.34 and within the company's strong operational context: latest quarter revenue of $383,152,000.00 with net income of $63,420,000.00, annual revenue growth of 16.9%, and a P/E of 18.26. The current market price of $24.10 sits only 0.07 below the transaction price, and the 30-day and 90-day price changes are modest at -2.1% and -3.4% respectively, suggesting modest recent momentum shifts. This represents his first documented discretionary open-market purchase at AROC and his second cumulative buy across all tickers, marking a meaningful capital commitment to the company at a point in the valuation cycle where the stock is trading well below its 52-week peak.